propranolol has been researched along with Weight Loss in 13 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
| " This study demonstrates that autonomic nervous system dysfunction occurs and is responsible for the elevated BMR in elderly cancer patients, propranolol administration rectifies the autonomic dysfunction, and Intralipid infusion combined with propranolol administration is useful for enhancing the daily caloric intake without a strong increase in energy expenditure." | 2.69 | Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients. ( Gambardella, A; Paolisso, G; Pesce, L; Tagliamonte, MR; Tortoriello, R; Varricchio, M, 1999) |
| "Atenolol treatment reduced REE by 77+/-14 kcal/day and propranolol by 48+/-13 kcal/day, respectively (P<0." | 2.69 | Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. ( Daneryd, P; Hyltander, A; Körner, U; Lundholm, K; Sandström, R, 2000) |
| "Propranolol treatment was associated with a significant reduction in plasma concentrations of free fatty acids (FFA), but not in plasma glycerol." | 2.67 | Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. ( Hyltander, A; Körner, U; Lundholm, KG, 1993) |
| "Hyperthyroidism is classically manifested by signs of hypercatabolism." | 2.42 | [Hyperthyroid rheumatism. Review of the literature and a case report]. ( Bergheul, S; Brinkane, A; Crickx, L; Levy, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Narayanan, S | 1 |
| Wang, S | 1 |
| Vasukuttan, V | 1 |
| Vyas Devambatla, RK | 1 |
| Dai, D | 1 |
| Jin, C | 1 |
| Snyder, R | 1 |
| Laudermilk, L | 1 |
| Runyon, SP | 1 |
| Maitra, R | 1 |
| Lopez, AJ | 1 |
| ElSaadani, M | 1 |
| Culkin, MC | 1 |
| Jacovides, CL | 1 |
| Georges, AP | 1 |
| Song, H | 1 |
| Kaplan, LJ | 1 |
| Kumar, MA | 1 |
| Smith, DH | 1 |
| Pascual, JL | 1 |
| Bisschop, PH | 1 |
| van Trotsenburg, AS | 1 |
| Chou, HK | 1 |
| Tsao, YT | 1 |
| Lin, SH | 1 |
| Drakaki, A | 1 |
| Habib, M | 1 |
| Sweeney, AT | 1 |
| Hazut, O | 1 |
| Shaashua, L | 1 |
| Benish, M | 1 |
| Levi, B | 1 |
| Sorski, L | 1 |
| Benjamin, B | 1 |
| Hoffman, A | 1 |
| Zmora, O | 1 |
| Ben-Eliyahu, S | 1 |
| Brinkane, A | 1 |
| Crickx, L | 1 |
| Bergheul, S | 1 |
| Levy, R | 1 |
| Hyltander, A | 2 |
| Körner, U | 2 |
| Lundholm, KG | 1 |
| Gambardella, A | 1 |
| Tortoriello, R | 1 |
| Pesce, L | 1 |
| Tagliamonte, MR | 1 |
| Paolisso, G | 1 |
| Varricchio, M | 1 |
| Daneryd, P | 1 |
| Sandström, R | 1 |
| Lundholm, K | 1 |
| van Aggel-Leijssen, DP | 1 |
| Saris, WH | 1 |
| Hul, GB | 1 |
| van Baak, MA | 1 |
| Russell, ST | 1 |
| Hirai, K | 1 |
| Tisdale, MJ | 1 |
| Freis, ED | 1 |
| Reda, DJ | 1 |
| Materson, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Walking on Spontaneous Physical Activity and on Lipid Oxidation Following Dietary Treatment of Obesity[NCT00775970] | 20 participants (Anticipated) | Interventional | 2008-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Weight Loss
| Article | Year |
|---|---|
[Hyperthyroid rheumatism. Review of the literature and a case report].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Asthenia; Carbimazole; Drug Therapy, Combination; F | 2003 |
5 trials available for propranolol and Weight Loss
| Article | Year |
|---|---|
Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours.
Topics: Basal Metabolism; Energy Metabolism; Female; Hormones; Humans; Indomethacin; Male; Morphine; Neoplas | 1993 |
Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients.
Topics: Adrenergic beta-Antagonists; Aged; Basal Metabolism; Cachexia; Calorimetry, Indirect; Catecholamines | 1999 |
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Cachexia; Calorimetry, Indirect; Carbohydrate Metabolism; Ene | 2000 |
Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Diet, Reducing; Energy Intake; Exercise; F | 2001 |
Volume (weight) loss and blood pressure response following thiazide diuretics.
Topics: Black People; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazi | 1988 |
7 other studies available for propranolol and Weight Loss
| Article | Year |
|---|---|
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.
Topics: Animals; Apelin Receptors; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Pyra | 2021 |
Persistent Blunting of Penumbral Leukocyte Mobilization by Beta Blockade Administered for Two Weeks After Traumatic Brain Injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries, Traumatic; Disease Models, Animal; Leukoc | 2022 |
Images in clinical medicine. Neonatal thyrotoxicosis.
Topics: Adult; Apgar Score; Eyelids; Female; Fetal Growth Retardation; Graves Disease; Heart Rate, Fetal; Hu | 2014 |
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Hypokalemic periodic paralysis due to Graves Disease.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Anxiety; Arrhythmias, Cardiac; Dyspnea; Graves Di | 2009 |
The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
Topics: Abdominal Wall; Adrenergic beta-Antagonists; Anastomosis, Surgical; Animals; Colon; Cyclooxygenase 2 | 2011 |
Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor.
Topics: Adenylyl Cyclases; Adipocytes; Animals; Appetite Depressants; CHO Cells; Cricetinae; Cyclic AMP; Epi | 2002 |